Meditation Awareness Training for the Treatment of Fibromyalgia Syndrome

Study Overview
=================
Brief Summary
-----------------
A Randomised Controlled Trial to evaluate the effectiveness of a Second-Generation Mindfulness-Based Intervention known as Meditation Awareness Training (MAT) for treating fibromyalgia syndrome.

Detailed Description
-----------------
Background: Fibromyalgia syndrome (FMS) is a chronic pain disorder that frequently leads to poor quality of life. The need for more effective FMS treatments has prompted empirical investigations into the applications of mindfulness for treating the condition. However, studies have predominantly focused on first-generation mindfulness-based interventions (FG-MBIs). To date, a randomised controlled trial (RCT) assessing the effectiveness of a second-generation mindfulness-based intervention (SG-MBI) for treating FMS has not been undertaken. SG-MBIs are distinct from FG-MBIs because they are overtly spiritual in nature and employ (i) a greater range of (normally secularised) meditative/spiritual techniques, (ii) ethics as a key component of the taught programme, and (iii) an instructor training programme that typically requires several years of supervised mindfulness practice. Aims: To evaluate the effectiveness of Meditation Awareness Training (MAT) - an SG-MBI - for treating FMS. Method: Adults with FMS will receive MAT or an active control intervention known as Cognitive-Behavioural Therapy for Groups. Assessments will be performed at pre-intervention, post-intervention, and follow-up phases.

Official Title
-----------------
Meditation Awareness Training for the Treatment of Fibromyalgia Syndrome: A Randomised Controlled Trial

Conditions
-----------------
Fibromyalgia Syndrome

Intervention / Treatment
-----------------
* Behavioral: Meditation Awareness Training
* Behavioral: Cognitive Behavioral Therapy for Groups


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Current diagnosis of fibromyalgia syndrome Aged between 18 and 65 years Able to read and write using the English language Available to complete an eight-week intervention and six-month follow-up assessment Exclusion Criteria: Currently undergoing formal psychotherapy Changes in psychopharmacology type or dosage one-month prior to intervention Currently practicing mindfulness or meditation

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Meditation Awareness Training<br>Target Intervention Arm: 8-week meditation intervention | Behavioral: Meditation Awareness Training<br>* 8 Week Meditation Intervention<br>|
| Active Comparator: Cognitive Behavioural Therapy for Groups<br>Active Comparator Arm: 8-week CBT-based intervention | Behavioral: Cognitive Behavioral Therapy for Groups<br>* 8 week intervention based on Cognitive Behavioral Theory<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Revised Fibromyalgia Impact Questionnaire | Scale Reference: Bennett, Friend, Jones, Ward, Han & Ross (2009) | 8 weeks | 
| Short Form McGill Pain Questionnaire | Scale Reference: Melzack (1987) | 8 weeks | 
| Pittsburgh Sleep Quality Index | Scale Reference: Buysse, Reynolds Monk, Berman, & Kupfer (1989) | 8 weeks | 
| Depression Anxiety and Stress Scale | Scale Reference: Lovibond & Lovibond (1995) | 8 weeks | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Fibromyalgia Syndromey